Outpatient Thyroid Lobectomy for Thyroid Disease
Trial Summary
What is the purpose of this trial?
To compare same-day discharge and overnight (or longer) observation practices and learn more about the differences in patient preferences, safety outcomes, and economic and resource impact
Will I have to stop taking my current medications?
If you are taking medications that increase the risk of bleeding, like Aspirin or blood thinners, you will need to stop them 5 days before surgery. For other medications, the trial protocol does not specify any requirements.
What data supports the effectiveness of the treatment Outpatient Thyroid Lobectomy for Thyroid Disease?
Research shows that outpatient preoperative assessment clinics provide benefits to patients and the healthcare system, suggesting that outpatient thyroid lobectomy could be feasible and safe. Additionally, patient-reported outcome measures have been validated for thyroid disease, indicating that patients can effectively report their symptoms and response to surgery.12345
Is outpatient thyroid lobectomy generally safe for humans?
How is outpatient thyroid lobectomy different from other treatments for thyroid disease?
Outpatient thyroid lobectomy is unique because it allows patients to have thyroid surgery without needing to stay overnight in the hospital, which is different from traditional inpatient care. This approach is shown to be safe and feasible, making it a convenient option for selected patients.311121314
Research Team
Paul Graham, M D
Principal Investigator
M.D. Anderson Cancer Center
Eligibility Criteria
This trial is for adults over 18 who are having their first thyroid lobectomy. It's open to both English and non-English speakers. People can't join if they have a high bleeding risk, severe health problems, live too far from the hospital, lack post-surgery support at home, or are pregnant.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Participants complete a survey about the severity of symptoms at the pre-surgery visit
Surgery and Immediate Post-operative
Participants undergo thyroid lobectomy and are either discharged the same day or observed overnight
Follow-up
Participants are monitored for safety and effectiveness, including symptom severity scores at 24 hours and 2 weeks post-procedure
Treatment Details
Interventions
- Post-Surgery Surveys (Behavioral Intervention)
- Pre-Surgery Survey (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor
Dr. Peter WT Pisters
M.D. Anderson Cancer Center
Chief Executive Officer since 2017
MD from University of Western Ontario
Dr. Jeffrey E. Lee
M.D. Anderson Cancer Center
Chief Medical Officer
MD from Stanford University School of Medicine